Curran Terrie (CIK 1690298) reported 3 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-06-09). Recent activity: Buy ARQT (5,778 shares), Buy ARQT (7,609 shares), Sell PHAT (19,109 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-09 | Arcutis Biotherapeutics, Inc. (ARQT) | Director | Buy | 5,778 | $0 |
| 2025-06-16 | Arcutis Biotherapeutics, Inc. (ARQT) | Director | Buy | 7,609 | $0 |
| 2025-01-23 | Phathom Pharmaceuticals, Inc. (PHAT) | President and Chief Executive | Sell | 19,109 | $125,928 |
Source: SEC Form 4 filings · as of 2026-06-09